• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB1800979 帕利哌酮缓释片 paliperidone Tablet, extended release Chemical Drugs Supplementary Application 2018-09-07 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2018-10-29 view
JYHB2000909 卡格列净片 canagliflozin Tablet Chemical Drugs(5.1) Supplementary Application 2020-06-20 Janssen-Cilag International NV Janssen-Cilag International NV Filed 2020-06-24 view
JYHZ1900269 醋酸阿比特龙片 abiraterone acetate Tablet Chemical Drugs License Renew 2019-10-15 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2020-03-09 view
JYHB1700414 帕利哌酮缓释片 paliperidone Tablet, extended release Chemical Drugs Supplementary Application 2017-03-30 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2017-10-12 view
JYHB1900589 帕利哌酮缓释片 paliperidone Tablet, extended release Chemical Drugs Supplementary Application 2019-05-20 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2019-06-05 view
JYHB2000866 帕利哌酮缓释片 paliperidone Tablet, extended release Chemical Drugs Supplementary Application 2020-06-18 Janssen-Cilag International NV Janssen-Cilag International NV Filed 2020-06-22 view
JXSL1400043 注射用司妥昔单抗 siltuximab Lyophilized Biological Products Import Drug Application 2014-09-12 Janssen-Cilag International NV Janssen-Cilag International NV In Review 2014-09-11 view
JYHB1801428 棕榈帕利哌酮酯注射液(3M) paliperidone palmitate Injection Chemical Drugs Supplementary Application 2018-12-12 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2019-02-26 view
JYSB2000519 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2020-10-16 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2020-11-23 view
JYSB2000095 乌司奴单抗注射液(静脉输注) Ustekinumab Injection Biological Products Supplementary Application 2020-03-24 Janssen-Cilag International NV Janssen-Cilag International NV Filed 2020-03-30 view
JXHL1200301 Ibrutinib胶囊 ibrutinib Capsule Chemical Drugs Import Drug Application 2012-10-10 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2013-04-17 view
JXSL1800037 乌司奴单抗注射液 Ustekinumab Injection Biological Products Import Drug Application 2018-10-22 Janssen-Cilag International NV Janssen-Cilag International NV In Review 2018-10-20 view
JXSS2000019 达雷妥尤单抗注射液 daratumumab Injection Biological Products Import Drug Application 2020-07-03 Janssen-Cilag International NV Janssen-Cilag International NV In Review 2020-07-02 view
JYHB1901497 棕榈帕利哌酮酯注射液(3M) paliperidone palmitate Injection Chemical Drugs Supplementary Application 2019-12-06 Janssen-Cilag International NV Janssen-Cilag International NV Filed 2019-12-13 view
JYSB1800102 乌司奴单抗注射液 Ustekinumab Injection Biological Products Supplementary Application 2018-05-10 Janssen-Cilag International NV Janssen-Cilag International NV Filed 2018-05-22 view
JYHF1900083 帕利哌酮缓释片 paliperidone Tablet, extended release Chemical Drugs Supplementary Application 2019-06-20 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2019-07-09 view
JYHB1501364 达芦那韦片 darunavir Tablet Chemical Drugs Supplementary Application 2015-10-21 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2016-07-25 view
JYSB1800275 乌司奴单抗注射液 Ustekinumab Injection Biological Products Supplementary Application 2018-12-27 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2019-02-27 view
JYHB2002635 棕榈酸帕利哌酮注射液 paliperidone palmitate Injection Chemical Drugs Supplementary Application 2020-12-21 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2021-01-14 view
JYHB2000426 帕利哌酮缓释片 paliperidone Tablet, extended release Chemical Drugs Supplementary Application 2020-04-08 Janssen-Cilag International NV Janssen-Cilag International NV Filed 2020-04-17 view